GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease.

Yi-Sun Yang,Hsin-Hung Chen,Chien-Ning Huang,Chung Y Hsu,Kai-Chieh Hu,Chia-Hung Kao

Diabetes care（2022）

引用 10|浏览7

暂无评分

摘要

Longer use and higher dose of GLP-1 RAs were associated with a decreased risk of hospitalization for ischemic stroke among Asian patients with T2D who did not have established atherosclerotic cardiovascular diseases, but who did have dyslipidemia or hypertension.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要